{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:12:50Z","timestamp":1788858770783,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.peptides.2007.10.024","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:14:59Z","timestamp":1196468099000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam\/piperacillin in a neutropenic mouse model of polymicrobial peritonitis"],"prefix":"10.1016","volume":"29","author":[{"given":"Oscar","family":"Cirioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ghiselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Kamysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenza","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mocchegiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Di Matteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Kamysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Scalise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giacometti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2007.10.024_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00134-001-1143-z","article-title":"Epidemiology of sepsis and infection in ICU patients from an international multicenter cohort study","volume":"28","author":"Alberti","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.peptides.2007.10.024_bib2","first-page":"1489","article-title":"The influence of G-CSF addition to antibiotic treatment of experimental sepsis on pulmonary tissue","volume":"97","author":"Aydin","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.peptides.2007.10.024_bib3","first-page":"331","article-title":"Evaluation of factors affecting mortality rate after sepsis induced by cecal ligation model","volume":"94","author":"Baker","year":"1983","journal-title":"Surgery"},{"key":"10.1016\/j.peptides.2007.10.024_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.dci.2003.09.010","article-title":"Regulation of myeloid development and function by colony-stimulating factors","volume":"28","author":"Barreda","year":"2004","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.peptides.2007.10.024_bib5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.326.7383.262","article-title":"Pathogenesis of sepsis: new concepts and implications for future treatment","volume":"326","author":"Bochud","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.peptides.2007.10.024_bib6","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/AAC.49.5.1727-1732.2005","article-title":"Immunomodulatory activities of small host defense peptides","volume":"49","author":"Bowdish","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.peptides.2007.10.024_bib7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.peptides.2007.01.001","article-title":"In vitro activities of the antimicrobial peptide tachyplesin III against Pseudomonas aeruginosa","volume":"28","author":"Cirioni","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.024_bib8","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.peptides.2006.05.004","article-title":"Experimental study on the efficacy of combination of \u03b1-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides","volume":"27","author":"Cirioni","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.024_bib9","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A6. Villanova, PA, 2003."},{"issue":"Suppl. C","key":"10.1016\/j.peptides.2007.10.024_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/27.suppl_C.29","article-title":"Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections","volume":"27","author":"Craig","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.peptides.2007.10.024_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MOG.0b013e32803cadf4","article-title":"Innate immune defenses in the intestinal tract","volume":"23","author":"Dann","year":"2007","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.peptides.2007.10.024_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3011.1990.tb00939.x","article-title":"Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids","volume":"35","author":"Fields","year":"1990","journal-title":"Int J Pep Prot Res"},{"key":"10.1016\/j.peptides.2007.10.024_bib13","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.peptides.2003.07.027","article-title":"Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock","volume":"24","author":"Giacometti","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.024_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.peptides.2004.09.012","article-title":"Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock","volume":"26","author":"Giacometti","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.024_bib15","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.peptides.2005.03.009","article-title":"In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection","volume":"26","author":"Giacometti","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.024_bib16","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0140-6736(91)91452-Z","article-title":"Septic shock: pathogenesis","volume":"338","author":"Glauser","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2007.10.024_bib17","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/iai.64.12.4922-4927.1996","article-title":"Antiendotoxin activity of cationic peptide antimicrobial agents","volume":"64","author":"Gough","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.peptides.2007.10.024_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(01)00092-5","article-title":"Cationic peptides: effectors in innate immunity and novel antimicrobials","volume":"1","author":"Hancock","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.peptides.2007.10.024_bib19","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.peptides.2007.10.024_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0005-2736(02)00358-9","article-title":"Specific interactions of the antimicrobial peptides cyclic \u03b2-sheet tachyplesin I with lipopolysaccharides","volume":"1562","author":"Hirakura","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.peptides.2007.10.024_bib21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"Guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.peptides.2007.10.024_bib22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1073\/pnas.56.2.488","article-title":"In vitro control of the development of macrophage and granulocyte colonies","volume":"56","author":"Ichikawa","year":"1966","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2007.10.024_bib23","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1128\/AAC.42.11.2966","article-title":"Prospective randomized comparison of imipenem-cilastatin and piperacillin\u2013tazobactam in nosocomial pneumonia or peritonitis","volume":"42","author":"Jaccard","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.peptides.2007.10.024_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1517\/14656566.8.2.167","article-title":"Intra-abdominal infections: considerations form the use carbapenems","volume":"8","author":"Kioumis","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.peptides.2007.10.024_bib25","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/383050","article-title":"Management of fever in neutropenic patients with different risk of complications","volume":"39","author":"Klastersky","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.peptides.2007.10.024_bib26","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/344654","article-title":"Bacterial resistance: origins, epidemiology, and impact","volume":"1","author":"Livermore","year":"2003","journal-title":"Clin Infect Dis Suppl"},{"key":"10.1016\/j.peptides.2007.10.024_bib27","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1097\/01.shk.0000191344.21228.b6","article-title":"The effects of granulocyte colony-stimulating factor in preclinical models of infection and acute inflammation","volume":"24","author":"Marshall","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.peptides.2007.10.024_bib28","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.peptides.2007.10.024_bib29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/jac\/28.3.447","article-title":"Effect of combination therapy with recombinant human granulocyte colony-stimulating factor (rG-CSF) and antibiotics in Neutropenic mice unresponsive to antibiotics alone","volume":"28","author":"Matsumoto","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.peptides.2007.10.024_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1367-5931(99)00025-3","article-title":"Synergy and duality in peptide antibiotic mechanisms","volume":"3","author":"McCafferty","year":"1999","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.peptides.2007.10.024_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI3216","article-title":"Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia","volume":"102","author":"McLemore","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.peptides.2007.10.024_bib32","doi-asserted-by":"crossref","first-page":"16709","DOI":"10.1016\/S0021-9258(18)37448-9","article-title":"A class of antimicrobial peptide from the hemocytes of horseshoe crab (Tachypleus tridentatus)","volume":"263","author":"Nakamura","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2007.10.024_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1009885830385","article-title":"The use of immunocompromised animals in sepsis research","volume":"2","author":"Opal","year":"1999","journal-title":"Sepsis"},{"key":"10.1016\/j.peptides.2007.10.024_bib34","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/01.shk.0000191335.93412.3e","article-title":"The use of immunocompromised animals as models for human septic shock","volume":"24","author":"Opal","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.peptides.2007.10.024_bib35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00005373-199211000-00014","article-title":"Treatment of intra-abdominal infections with granulocyte colony-stimulating factor","volume":"33","author":"O\u2019Really","year":"1992","journal-title":"J Trauma"},{"key":"10.1016\/j.peptides.2007.10.024_bib36","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/00003495-199957050-00017","article-title":"Piperacillin\/tazobactam: an updated review of its use in the treatment of bacterial infections","volume":"57","author":"Perry","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.peptides.2007.10.024_bib37","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1128\/AAC.40.8.1801","article-title":"Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria","volume":"40","author":"Vaara","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.peptides.2007.10.024_bib38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1086\/515643","article-title":"Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis","volume":"178","author":"Villa","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.peptides.2007.10.024_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000658-199607000-00003","article-title":"Management of secondary peritonitis","volume":"224","author":"Wittmann","year":"1996","journal-title":"Ann Surg"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978107004391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978107004391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:19:37Z","timestamp":1759310377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978107004391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0196978107004391"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2007.10.024","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam\/piperacillin in a neutropenic mouse model of polymicrobial peritonitis","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2007.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}